|
gptkbp:instance_of
|
gptkb:Ophthalmology
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:available_in
|
gptkb:various_countries
|
|
gptkbp:brand
|
gptkb:Vigamox
|
|
gptkbp:capacity
|
5 m L
|
|
gptkbp:category
|
Category C
|
|
gptkbp:class
|
fluoroquinolone antibiotic
|
|
gptkbp:clinical_trial
|
Phase III
ongoing studies
studies on efficacy
|
|
gptkbp:clinical_use
|
ophthalmology
|
|
gptkbp:color
|
clear yellowish solution
clear yellow solution
|
|
gptkbp:community_service
|
safety not established
|
|
gptkbp:contraindication
|
hypersensitivity to moxifloxacin
not for viral infections
|
|
gptkbp:counseling_services
|
do not touch dropper tip
|
|
gptkbp:dosage_form
|
gptkb:Software_Solutions
1 drop in the affected eye(s) three times a day
|
|
gptkbp:drug_interactions
|
none significant
|
|
gptkbp:duration
|
7 days
up to 24 hours
|
|
gptkbp:effective_date
|
gptkb:2003
FDA approved
|
|
gptkbp:expansion
|
isotonic
|
|
gptkbp:form
|
0.5% solution
|
|
gptkbp:formulation
|
gptkb:cream
sterile solution
|
|
gptkbp:healthcare
|
gptkb:liquid
sterile solution
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Vigamox
|
|
gptkbp:indication
|
bacterial eye infections
|
|
gptkbp:ingredients
|
gptkb:moxifloxacin
|
|
gptkbp:interacts_with
|
other topical ophthalmic agents
|
|
gptkbp:is_effective_against
|
effective against common pathogens
|
|
gptkbp:manufacturer
|
gptkb:Alcon_Laboratories
gptkb:Alcon
|
|
gptkbp:marketed_as
|
gptkb:2003
antibiotic eye drops
|
|
gptkbp:mechanism_of_action
|
inhibits bacterial DNA gyrase
|
|
gptkbp:p_hlevel
|
6.0 to 7.0
|
|
gptkbp:packaging
|
gptkb:bottle
|
|
gptkbp:patient_information_leaflet
|
included in packaging
|
|
gptkbp:patient_population
|
adults and children
|
|
gptkbp:pharmacokinetics
|
rapid absorption
bactericidal activity
|
|
gptkbp:pharmacy_availability
|
widely available
|
|
gptkbp:premiered_on
|
within hours
|
|
gptkbp:previous_name
|
gptkb:moxifloxacin_hydrochloride
|
|
gptkbp:price
|
varies by pharmacy
|
|
gptkbp:provides_guidance_on
|
recommended for acute bacterial conjunctivitis
|
|
gptkbp:requires
|
available online
prescription only
|
|
gptkbp:route_of_administration
|
topical
ocular
topical ophthalmic
|
|
gptkbp:safety
|
Category C
not for injection
|
|
gptkbp:safety_features
|
generally well tolerated
|
|
gptkbp:safety_measures
|
monitor for allergic reactions
|
|
gptkbp:service_frequency
|
3 times a day
|
|
gptkbp:shelf_life
|
24 months
3 years
check packaging
|
|
gptkbp:side_effect
|
headache
dry eyes
eye irritation
taste disturbance
conjunctival hyperemia
eyelid edema
|
|
gptkbp:size
|
5 m L bottle
|
|
gptkbp:storage
|
room temperature
store at room temperature
|
|
gptkbp:strength
|
0.5%
|
|
gptkbp:therapeutic_category
|
gptkb:pharmaceuticals
|
|
gptkbp:treatment
|
resolution of symptoms
|
|
gptkbp:type_of_care
|
important for treatment success
|
|
gptkbp:used_for
|
treatment of bacterial conjunctivitis
|
|
gptkbp:bfsParent
|
gptkb:Bausch_+_Lomb_Eye_Products_Inc.
gptkb:Bausch_+_Lomb_Eye_Products_Ltd.
gptkb:Valeant_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
6
|